AU Stock MarketDetailed Quotes

PARO Paradigm Biopharmaceuticals Ltd

Watchlist
  • 0.004
  • 0.0000.00%
20min DelayNot Open Oct 14 10:09 AET
1.40MMarket Cap0.00P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
40.72%65.8K
-40.98%46.76K
285.52%79.22K
20.55K
Operating revenue
40.72%65.8K
-40.98%46.76K
285.52%79.22K
--20.55K
----
----
Cost of revenue
-52.26%8.99K
-86.90%18.83K
45.00%143.75K
99.14K
Gross profit
103.39%56.81K
143.29%27.93K
17.89%-64.53K
-78.59K
Operating expense
8.63%65.25M
25.33%60.07M
10.65%47.93M
152.21%43.31M
67.98%17.17M
10.22M
Selling and administrative expenses
-5.31%6.22M
-17.26%6.56M
-9.30%7.93M
109.96%8.75M
79.71%4.17M
--2.32M
-General and administrative expense
-5.31%6.22M
-17.26%6.56M
-9.30%7.93M
109.96%8.75M
79.71%4.17M
--2.32M
Research and development costs
10.73%58.33M
35.03%52.68M
16.39%39.01M
161.98%33.52M
62.01%12.79M
--7.9M
Depreciation amortization depletion
--146.74K
----
-70.98%60.97K
-1.44%210.06K
2,452.92%213.12K
--8.35K
-Depreciation and amortization
--146.74K
----
-70.98%60.97K
-1.44%210.06K
2,452.92%213.12K
--8.35K
Other operating expenses
-32.71%553.61K
-10.47%822.7K
9.80%918.86K
--836.88K
----
----
Operating profit
-8.59%-65.19M
-25.10%-60.04M
-10.60%-47.99M
-152.66%-43.39M
-67.98%-17.17M
-10.22M
Net non-operating interest income (expenses)
-71.67%392.64K
5,897.84%1.39M
-86.52%23.11K
-82.21%171.4K
268.15%963.48K
261.71K
Non-operating interest income
-70.98%407.01K
2,610.61%1.4M
-75.26%51.74K
-79.04%209.13K
281.20%997.65K
--261.71K
Non-operating interest expense
-12.46%14.37K
-42.67%16.42K
-24.09%28.63K
10.40%37.72K
--34.17K
----
Other net income (expenses)
-11.00%6M
-22.12%6.74M
-0.63%8.66M
135.60%8.71M
165.17%3.7M
-5.67M
Special income (charges)
----
----
----
----
----
---6.93M
-Less:Impairment of capital assets
----
----
----
----
----
--6.93M
Other non-operating income (expenses)
-11.00%6M
-22.12%6.74M
-0.63%8.66M
135.60%8.71M
194.66%3.7M
--1.25M
Income before tax
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-15.63M
Income tax
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-15.63M
Net income continuous operations
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
---15.63M
Noncontrolling interests
Net income attributable to the company
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-15.63M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-12.99%-58.65M
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-15.63M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue 40.72%65.8K-40.98%46.76K285.52%79.22K20.55K
Operating revenue 40.72%65.8K-40.98%46.76K285.52%79.22K--20.55K--------
Cost of revenue -52.26%8.99K-86.90%18.83K45.00%143.75K99.14K
Gross profit 103.39%56.81K143.29%27.93K17.89%-64.53K-78.59K
Operating expense 8.63%65.25M25.33%60.07M10.65%47.93M152.21%43.31M67.98%17.17M10.22M
Selling and administrative expenses -5.31%6.22M-17.26%6.56M-9.30%7.93M109.96%8.75M79.71%4.17M--2.32M
-General and administrative expense -5.31%6.22M-17.26%6.56M-9.30%7.93M109.96%8.75M79.71%4.17M--2.32M
Research and development costs 10.73%58.33M35.03%52.68M16.39%39.01M161.98%33.52M62.01%12.79M--7.9M
Depreciation amortization depletion --146.74K-----70.98%60.97K-1.44%210.06K2,452.92%213.12K--8.35K
-Depreciation and amortization --146.74K-----70.98%60.97K-1.44%210.06K2,452.92%213.12K--8.35K
Other operating expenses -32.71%553.61K-10.47%822.7K9.80%918.86K--836.88K--------
Operating profit -8.59%-65.19M-25.10%-60.04M-10.60%-47.99M-152.66%-43.39M-67.98%-17.17M-10.22M
Net non-operating interest income (expenses) -71.67%392.64K5,897.84%1.39M-86.52%23.11K-82.21%171.4K268.15%963.48K261.71K
Non-operating interest income -70.98%407.01K2,610.61%1.4M-75.26%51.74K-79.04%209.13K281.20%997.65K--261.71K
Non-operating interest expense -12.46%14.37K-42.67%16.42K-24.09%28.63K10.40%37.72K--34.17K----
Other net income (expenses) -11.00%6M-22.12%6.74M-0.63%8.66M135.60%8.71M165.17%3.7M-5.67M
Special income (charges) -----------------------6.93M
-Less:Impairment of capital assets ----------------------6.93M
Other non-operating income (expenses) -11.00%6M-22.12%6.74M-0.63%8.66M135.60%8.71M194.66%3.7M--1.25M
Income before tax -12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-15.63M
Income tax 000000
Earnings from equity interest net of tax
Net income -12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-15.63M
Net income continuous operations -12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M---15.63M
Noncontrolling interests
Net income attributable to the company -12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-15.63M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -12.99%-58.65M-32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-15.63M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data